Topic

UnitedHealthcare (UnitedHealth Group)

A collection of 1322 issues

Complete Guide: Getting Imbruvica (ibrutinib) Covered by UnitedHealthcare in Pennsylvania - Prior Authorization, Appeals, and Success Strategies

Answer Box: Your Path to Imbruvica Coverage in Pennsylvania Getting Imbruvica (ibrutinib) covered by UnitedHealthcare in Pennsylvania requires prior authorization, proper diagnosis documentation, and often step therapy compliance. Most approvals take 5-15 business days with complete submissions. If denied, Pennsylvania's new external review program has overturned 50% of
6 min read

How to Get Prolastin-C Covered by UnitedHealthcare in Ohio: Appeals Guide with Forms and Timelines

Answer Box: Getting Prolastin-C Covered by UnitedHealthcare in Ohio UnitedHealthcare requires prior authorization for Prolastin-C (alpha1-proteinase inhibitor), with approvals typically requiring severe AAT deficiency genotype (Pi*ZZ), documented emphysema, and specific lung function criteria. If denied, you have 21 calendar days to appeal through the UnitedHealthcare Provider Portal, followed by
7 min read

How to Get Eylea and Lucentis Covered by UnitedHealthcare in Texas: Prior Authorization Forms, Appeals, and Step Therapy Guide

Answer Box: Getting Started in Texas UnitedHealthcare requires prior authorization for both Eylea (aflibercept) and Lucentis (ranibizumab) in Texas, with step therapy typically requiring bevacizumab first unless contraindicated. Both drugs are placed in Tier 4 (Specialty) with higher copays or coinsurance. Fastest approval path: (1) Have your retina specialist submit
5 min read

How to Get Revlimid (Lenalidomide) Covered by UnitedHealthcare in California: A Complete Guide to Prior Authorization and Appeals

Quick Answer: Getting Revlimid Covered by UnitedHealthcare in California UnitedHealthcare requires prior authorization for Revlimid (lenalidomide) through OptumRx, with strict clinical criteria and REMS compliance. The fastest path to approval: (1) Ensure your oncologist submits a complete prior authorization with lab values, diagnosis codes, and treatment history through the UnitedHealthcare
5 min read

If Ultomiris (Ravulizumab) Isn't Approved by UnitedHealthcare in Michigan: Formulary Alternatives & Exception Strategies

Quick Answer: Your Options When Ultomiris Is Denied If UnitedHealthcare denies Ultomiris (ravulizumab) in Michigan, you have three main paths: try a formulary alternative like Soliris (eculizumab), request a formulary exception with medical necessity documentation, or pursue a formal appeal. Your fastest option is often requesting a peer-to-peer review where
6 min read

Coding That Helps Get Orkambi (Lumacaftor/Ivacaftor) Approved by UnitedHealthcare in Florida: ICD-10, HCPCS, and NDC Requirements

Answer Box: Quick Path to Orkambi Coverage Getting Orkambi (lumacaftor/ivacaftor) covered by UnitedHealthcare in Florida requires specific coding and documentation. Use ICD-10 code E84.0-E84.9 for cystic fibrosis manifestations, submit genetic testing confirming F508del homozygous status, and ensure a CF specialist prescribes the medication. Submit prior authorization through
6 min read

Renewing Fabrazyme (Agalsidase Beta) Approval with UnitedHealthcare in Michigan: 2025 Requirements and Timeline

Answer Box: Renewing Fabrazyme with UnitedHealthcare in Michigan Fabrazyme requires annual reauthorization with UnitedHealthcare, typically 12 months after initial approval. Start the renewal process 30 days before expiration to avoid coverage gaps. Submit updated clinical documentation showing treatment response through your provider's UnitedHealthcare portal or OptumRx system. If
5 min read